Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy

Cancer Discovery
Stephen J BlakeMark J Smyth

Abstract

CD96 has recently been shown as a negative regulator of mouse natural killer (NK)-cell activity, with Cd96(-/-)mice displaying hyperresponsive NK cells upon immune challenge. In this study, we have demonstrated that blocking CD96 with a monoclonal antibody inhibited experimental metastases in three different tumor models. The antimetastatic activity of anti-CD96 was dependent on NK cells, CD226 (DNAM-1), and IFNγ, but independent of activating Fc receptors. Anti-CD96 was more effective in combination with anti-CTLA-4, anti-PD-1, or doxorubicin chemotherapy. Blocking CD96 in Tigit(-/-)mice significantly reduced experimental and spontaneous metastases compared with its activity in wild-type mice. Co-blockade of CD96 and PD-1 potently inhibited lung metastases, with the combination increasing local NK-cell IFNγ production and infiltration. Overall, these data demonstrate that blocking CD96 is a new and complementary immunotherapeutic strategy to reduce tumor metastases. This article illustrates the antimetastatic activity and mechanism of action of an anti-CD96 antibody that inhibits the CD96-CD155 interaction and stimulates NK-cell function. Targeting host CD96 is shown to complement surgery and conventional immune checkpoint blo...Continue Reading

References

Jul 15, 1982·International Journal of Cancer. Journal International Du Cancer·E GorelikR B Herberman
Aug 13, 2003·The Journal of Experimental Medicine·Cristina BottinoAlessandro Moretta
Mar 23, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anja FuchsMarco Colonna
Mar 26, 2005·Immunological Reviews·Mary E Keir, Arlene H Sharpe
May 9, 2006·Nature Medicine·Tomoyasu UnoMark J Smyth
Jun 27, 2006·Nature Reviews. Immunology·David H Raulet, Russell E Vance
Feb 17, 2007·Nature Immunology·Arlene H SharpeGordon J Freeman
Jun 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jeremy B SwannMark J Smyth
Nov 1, 2007·Biochemical and Biophysical Research Communications·S SethG Bernhardt
Jan 5, 2008·Annual Review of Immunology·Mary E KeirArlene H Sharpe
Apr 22, 2008·Nature Immunology·Lewis L Lanier
Apr 22, 2008·Nature Immunology·Eric VivierSophie Ugolini
Sep 2, 2008·Immunological Reviews·Karl S PeggsJames P Allison
Nov 26, 2008·The Journal of Experimental Medicine·Susan GilfillanMarco Colonna
Dec 4, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Angela GiorginiMichael G Robson
Feb 7, 2009·European Journal of Immunology·Kent S BolesMarco Colonna
Apr 8, 2009·The Journal of Clinical Investigation·Tadepally LakshmikanthFrancesco Colucci
Oct 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Noa StanietskyOfer Mandelboim
Dec 17, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christopher J ChanMark J Smyth
Apr 21, 2010·Proceedings of the National Academy of Sciences of the United States of America·Michele W L TengMark J Smyth
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Mar 20, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ester LozanoDavid A Hafler
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Apr 13, 2013·Cell Death and Differentiation·C J ChanL Martinet
May 17, 2013·European Journal of Immunology·Noa StanietskyOfer Mandelboim
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Aug 29, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bertrand AllardJohn Stagg
Nov 6, 2013·Annual Review of Medicine·David B PageJedd D Wolchok
Aug 15, 2014·Nature Communications·Priyanka SatheNicholas D Huntington
Mar 7, 2015·Nature Reviews. Immunology·Ludovic Martinet, Mark J Smyth
Apr 14, 2015·The Journal of Clinical Investigation·Joe-Marc ChauvinHassane M Zarour
Apr 22, 2015·The New England Journal of Medicine·Michael A PostowF Stephen Hodi
May 23, 2015·Nature Reviews. Drug Discovery·Richard W Childs, Mattias Carlsten

❮ Previous
Next ❯

Citations

May 24, 2016·Nature Immunology·Rebecca B DelconteNicholas D Huntington
Mar 5, 2017·Immunological Reviews·William C DougallAna C Anderson
Jun 22, 2016·Nature Immunology·Laurence Zitvogel, Guido Kroemer
Oct 27, 2017·Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur̈ Transfusionsmedizin Und Immunham̈atologie·Joachim Koch, Michael Tesar
May 15, 2018·The Journal of Clinical Investigation·Xian-Yang LiMark J Smyth
Dec 7, 2017·Oncoimmunology·Abhishek D GargLorenzo Galluzzi
Jul 19, 2017·Cold Spring Harbor Perspectives in Biology·Juming YanMichele W L Teng
Oct 18, 2018·Immunotherapy·Dass S Vinay, Byoung S Kwon
Nov 10, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Haoyu SunCheng Sun
Mar 9, 2019·Journal of Leukocyte Biology·Mario Ernesto Cruz-MuñozJesus Santa-Olalla Tapia
Jul 18, 2019·Immunology·Lukman O AfolabiXiaochun Wan
Jun 6, 2018·Frontiers in Immunology·Hristo GeorgievGünter Bernhardt
Dec 13, 2019·Clinical and Experimental Immunology·H Harjunpää, C Guillerey
Jul 22, 2017·Cancer Science·Jian GaoChenghai Zhao
Feb 6, 2020·International Journal of Molecular Sciences·Rosa MolfettaRossella Paolini
Feb 11, 2020·The Journal of Experimental Medicine·Genki OkumuraKazuko Shibuya
Feb 12, 2020·European Journal of Immunology·Eugene Y ChiangJane L Grogan
Aug 30, 2019·International Journal of Cancer. Journal International Du Cancer·Won-Min SongBin Zhang
Apr 11, 2020·Journal for Immunotherapy of Cancer·Carla V Rothlin, Sourav Ghosh
Apr 18, 2020·Cancer Science·Kiho Miyazato, Yoshihiro Hayakawa
Mar 14, 2018·Proceedings of the National Academy of Sciences of the United States of America·Katarina StankoBirgit Sawitzki
Oct 11, 2017·Oncoimmunology·Alexandre IvagnèsLaurence Zitvogel
Dec 12, 2018·Nature Reviews. Clinical Oncology·Jake S O'DonnellMark J Smyth
Apr 7, 2019·Cancer Immunology, Immunotherapy : CII·Beatriz Sanchez-CorreaRaquel Tarazona
May 10, 2019·Oncoimmunology·Haiyan ZhangMark J Smyth
Feb 11, 2020·Frontiers in Immunology·Ombretta MelaiuDoriana Fruci
Mar 3, 2020·Frontiers in Immunology·Muhammad KhanHua Wang
Mar 11, 2020·Frontiers in Immunology·Aviad Ben-ShmuelMira Barda-Saad
Aug 23, 2018·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Hauke StammWalter Fiedler
Jun 20, 2019·Frontiers in Immunology·Silvia PesceEmanuela Marcenaro
Dec 6, 2019·JCI Insight·Lucas Ferrari de AndradeKai W Wucherpfennig
Aug 9, 2020·Molecular Cancer·Song-Yang WuZhi-Ming Shao
Dec 4, 2016·Hematology·Don M Benson
Jul 20, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Peter J Chockley, Venkateshwar G Keshamouni
Aug 20, 2016·Nature Immunology·Camille GuillereyMark J Smyth
Mar 30, 2017·Frontiers in Immunology·Paolo Carrega, Guido Ferlazzo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.